40200_2016_251_MOESM6_ESM.tif (546.83 kB)

Additional file 6: Figure S4. of Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study

Download (546.83 kB)
figure
posted on 02.08.2016, 05:00 by Thomas Wilke, Sabrina Mueller, Antje Groth, Bjoern Berg, Niklas Hammar, Katherine Tsai, Andreas Fuchs, Stephanie Stephens, Ulf Maywald
Kaplan-Meier (KM) curves for all-cause death rates, macrovascular event rates and T2DM-related hospitalizations for patients with either MET or SU monotherapy (PS matched groups). The figure shows KM curves representing the percentage of event-free patients (all-cause event as well as mortality, MACE and T2DM-related hospitalizations) for two T2DM-incident cohorts: patients who received SU monotherapy and patients who received MET monotherapy. Cohorts are matched by PSM. Observation started with the first observed SU/MET prescription. (TIF 546 kb)

Funding

AstraZeneca

History

Exports